Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now
- 1 August 2004
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 151 (2), 298-307
- https://doi.org/10.1111/j.1365-2133.2004.06132.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2001
- Early Recurrence After Lymphatic Mapping and Sentinel Node Biopsy in Patients With Primary Extremity Melanoma: A Comparison With Elective Lymph Node DissectionAnnals of Surgical Oncology, 2001
- ResponseDermatologic Surgery, 2001
- Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2000
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Gamma-probe guided localization of lymph nodesSurgical Oncology, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Lymphadenectomy in the Management of Stage I Malignant Melanoma: A Prospective Randomized StudyMayo Clinic Proceedings, 1986
- Malignant MelanomaAnnals of Surgery, 1953